Literature DB >> 22361405

Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction.

Toyoharu Oba1, Hideo Yasukawa, Masahiko Hoshijima, Ken-ichiro Sasaki, Nobuyoshi Futamata, Daisuke Fukui, Kazutoshi Mawatari, Takanobu Nagata, Sachiko Kyogoku, Hideki Ohshima, Tomoko Minami, Keiichiro Nakamura, Dongchon Kang, Toshitaka Yajima, Kirk U Knowlton, Tsutomu Imaizumi.   

Abstract

OBJECTIVES: The study investigated the role of myocardial suppressor of cytokine signaling-3 (SOCS3), an intrinsic negative feedback regulator of the janus kinase and signal transducer and activator of transcription (JAK-STAT) signaling pathway, in the development of left ventricular (LV) remodeling after acute myocardial infarction (AMI).
BACKGROUND: LV remodeling after AMI results in poor cardiac performance leading to heart failure. Although it has been shown that JAK-STAT-activating cytokines prevent LV remodeling after AMI in animals, little is known about the role of SOCS3 in this process.
METHODS: Cardiac-specific SOCS3 knockout mice (SOCS3-CKO) were generated and subjected to AMI induced by permanent ligation of the left anterior descending coronary artery.
RESULTS: Although the initial infarct size after coronary occlusion measured by triphenyltetrazolium chloride staining was comparable between SOCS3-CKO and control mice, the infarct size 14 days after AMI was remarkably inhibited in SOCS3-CKO, indicating that progression of LV remodeling after AMI was prevented in SOCS3-CKO hearts. Prompt and marked up-regulations of multiple JAK-STAT-activating cytokines including leukemia inhibitory factor and granulocyte colony-stimulating factor (G-CSF) were observed within the heart following AMI. Cardiac-specific SOCS3 deletion enhanced multiple cardioprotective signaling pathways including STAT3, AKT, and extracellular signal-regulated kinase (ERK)-1/2, while inhibiting myocardial apoptosis and fibrosis as well as augmenting antioxidant expression.
CONCLUSIONS: Enhanced activation of cardioprotective signaling pathways by inhibiting myocardial SOCS3 expression prevented LV remodeling after AMI. Our data suggest that myocardial SOCS3 may be a key molecule in the development of LV remodeling after AMI.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361405     DOI: 10.1016/j.jacc.2011.10.887

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

1.  Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development.

Authors:  Takaya Ishihara; Reiko Ban-Ishihara; Maki Maeda; Yui Matsunaga; Ayaka Ichimura; Sachiko Kyogoku; Hiroki Aoki; Shun Katada; Kazuto Nakada; Masatoshi Nomura; Noboru Mizushima; Katsuyoshi Mihara; Naotada Ishihara
Journal:  Mol Cell Biol       Date:  2014-10-27       Impact factor: 4.272

2.  Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Santosh Kumari; Bakhtiyor Yakubov; Andrea L Frump; Timothy A Hacker; Alessandro Bellofiore; Rongbo Li; Xin Sun; Kara N Goss; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

3.  High fat diet-induced obesity increases myocardial injury and alters cardiac STAT3 signaling in mice after polymicrobial sepsis.

Authors:  Theodore DeMartini; Marchele Nowell; Jeanne James; Lauren Williamson; Patrick Lahni; Hui Shen; Jennifer M Kaplan
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-15       Impact factor: 5.187

4.  SOCS2 inhibited mitochondria biogenesis via inhibiting p38 MAPK/ATF2 pathway in C2C12 cells.

Authors:  Lu Gan; Zhenjiang Liu; Zhenzhen Zhang; Xiaobo Yang; Jing Liu; Chao Sun
Journal:  Mol Biol Rep       Date:  2013-12-19       Impact factor: 2.316

Review 5.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

6.  Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.

Authors:  Fouad A Zouein; Carlos Zgheib; Shereen Hamza; John W Fuseler; John E Hall; Andrea Soljancic; Arnaldo Lopez-Ruiz; Mazen Kurdi; George W Booz
Journal:  Hypertens Res       Date:  2013-01-31       Impact factor: 3.872

7.  Myocardial Infarction Causes Transient Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via gp130.

Authors:  Antoinette Olivas; Ryan T Gardner; Lianguo Wang; Crystal M Ripplinger; William R Woodward; Beth A Habecker
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

8.  Bioinformatic Analysis of the Possible Regulative Network of miR-30a/e in Cardiomyocytes 2 Days Post Myocardial Infarction.

Authors:  Yiping Wang; Yingqiong Huang; Min Zhang; Xiaoqin Zhang; Xuemei Tang; Yan Kang
Journal:  Acta Cardiol Sin       Date:  2018-03       Impact factor: 2.672

9.  SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury.

Authors:  Shoichiro Nohara; Mai Yamamoto; Hideo Yasukawa; Takanobu Nagata; Jinya Takahashi; Koutatsu Shimozono; Toshiyuki Yanai; Tomoko Sasaki; Kota Okabe; Tatsuhiro Shibata; Daiki Akagaki; Kazutoshi Mawatari; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

Review 10.  Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function.

Authors:  Nehal J Patel; Drew M Nassal; Daniel Gratz; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2020-11-23       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.